Project Helps Improve Communication Between Clinicians & Patients With MS
“We saw a need to improve communication between patients and clinicians so that patients feel...
Read More
Author: Rebecca Shover
Highlights From AACR 2023
AACR 2023v4
Read More
Dr. MedLaw Q&A: Exploring What Constitutes “Treatment” and “Continuous” in Medical Malpractice
Q: As a family practitioner, I include a breast examination on a standard physical. About 3 years...
Read More
Immune Checkpoint Inhibition Improves Outcomes in Non-BRCA Variant Ovarian Cancer
Durvalumab and olaparib added to standard of care improved progression-free survival compared with...
Read More
Response-Directed Treatment Personalization in Stage III Melanoma
Trials find response evaluation of systemic neoadjuvant treatment in patients with stage III...
Read More
No Improved Survival in Pancreatic Cancer After Neoadjuvant mFOLFIRINOX
Neoadjuvant chemotherapy improved surgical outcomes in patients with resectable pancreatic head...
Read MoreAdding Chemotherapy to EGFR TKI Does Not Improve Overall Survival in Advanced NSCLC
Additional cisplatin/pemetrexed courses after initial EGFR TKI response improved progression-free but not overall survival compared with EGFR-TKI monotherapy. EGFR tyrosine kinase inhibitors (TKIs) are standard first-line...
Read More
Adjuvant Ribociclib Improves Invasive Disease-Free Survival in Early Breast Cancer
Adding ribociclib to endocrine therapy improved invasive and distant disease-free survival of...
Read More
Patients With Inflammatory Arthritis at High Risk for Psychiatric Comorbidities
Anxiety and depression are prevalent in patients with inflammatory arthritis; comorbid mental...
Read More
JAK Inhibitors: No Elevated MACE in a Real-World Treatment Scenario
JAK inhibitor treatment did not result in an increased risk for MACE compared with TNF inhibitors...
Read More
Long-Term Dose Reduction Viable With RA Disease Activity–Guided Strategy
Disease activity-driven dose reduction in patients with RA treated with b/ts DMARDs is not...
Read More
NAFLD in Psoriatic Disease: FIB-4 Is a Better Predictor of Liver Fibrosis
Patients with psoriatic arthritis have a higher risk for NAFLD and related liver fibrosis than...
Read More
Selective JAK1/TYK2 Inhibition: A Novel Way to Overcome Tofacitinib Resistance in RA?
Therapy with an investigative JAK1/TYK2 inhibitor led to remission in one-third of participants...
Read More
KRAS Mutation Does Not Influence Atezolizumab Response in NSCLC
This retrospective analysis of the IMpower150 trial (NCT02486718) explored efficacy endpoints...
Read More
De-Escalation of Neoadjuvant Treatment of Locally Advanced Rectal Cancer Is Non-Inferior
The PROSPECT study showed that neoadjuvant FOLFOX, with selective use of pelvic chemoradiation, is...
Read More
Erdafitinib Outperforms Chemotherapy in Patients With FGFR-Altered Advanced Urothelial Cancer
Patients with FGFR-altered advanced urothelial cancer benefit from erdafitinib after anti-PD-L1...
Read More
Adjuvant Nivolumab Treatment Decreases Risk for Recurrence in Stage II Melanoma
A biomarker analysis of CheckMate76 data showed that baseline tumor mutation burden and interferon...
Read More
Adding Pembrolizumab to Perioperative Chemotherapy Improves Event-Free Survival in Early-Stage NSCLC
In KEYNOTE-671, neoadjuvant pembrolizumab plus chemotherapy followed by surgery and adjuvant...
Read More
SONIA: No Survival Benefit of First-Line CDK4/6 Inhibition in Metastatic Breast Cancer
First-line CDK4/6 inhibition did not boost survival or QOL but did prolong CDK4/6 inhibitor use...
Read More
‘Inform and Empower’ Patients on PrEP to Start HPV Vaccine Series
Incorporating HPV vaccination into PrEP services may increase the number of patients who receive...
Read More